Hepatitis C virus (HCV) infection is highly prevalent among chronic kidney disease (CKD)
subjects under hemodialysis and in kidney transplantation (KT) recipients, being an …

Hepatitis C virus infection is still common among dialysis patients, but the natural history of
HCV in this group is not completely understood. Recent evidence has been accumulated …

The efficacy and safety of combined interferon (IFN) plus ribavirin in patients on long‐term
dialysis and chronic hepatitis C remains unclear, although a number of small clinical trials …

Asia is endemic for hepatitis C virus (HCV) infection, which is the leading cause of cirrhosis,
hepatic decompensation, hepatocellular carcinoma, and liver transplantation worldwide …

Background: patients on hemodialysis are at risk of nosocomial infections especially
Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV). Nurses' adherence to infection control …

Despite the introduction of strict hygienic precautions preventing infection spread of hepatitis
C virus (HCV) in dialysis settings, this infection is still prevalent among dialysis patients due …

The medical literature on mono‐therapy with pegylated interferon for chronic hepatitis C in
dialysis patients is mostly based on small clinical studies and the efficacy and safety of such …

AIM: To assess the efficacy and safety of combined pegylated interferon and ribavirin
therapy in hepatitis C virus (HCV) infection in renal transplant recipients. METHODS: This is …

The most frequent kidney disease associated with chronic hepatitis C virus (HCV) infection
is membranoproliferative glomerulonephritis in patients with type II mixed …

Background The updated estimates of hepatitis C virus (HCV) seroprevalence are critical for
developing strategies to manage or eliminate HCV infection. Methods A comprehensive …